[ad_1]
Mayra Galindo Leal, Director of the Mexican Association for the Fight Against Cancer (AMLCC), emphasized the urgency of implementing the recent Mexican Official Standard 048 (NOM-048-SSA2-2017) for the treatment of prostate cancer because, he said, despite being approved in December last year, but has not yet been implemented in all hospitals.
This would significantly reduce the risk of death related to this condition (between five and seven thousand deaths per year) and provide a quality of life for patients with prostate cancer, so it is urgent, at least he reiterated, that every hospital clinic and health center in the country implement this NOM.
He recalled that prostate cancer is the leading cause of death among men, with seven thousand deaths a year, while he warned that the approved prostate cancer care in our country was an outstanding debt with thousands of patients with this disease.
At a press conference, he also pointed out that since last December there is the aforementioned NAME for prostate cancer, "which, given its mandatory nature, provides the necessary foundation for its care optimal in all health facilities, positively unify the management of this disease that takes more lives than mom's cancer, "he said.
Dr. Maria Esther Lozano Dávila, Deputy Director of the National Program of Attention to Aging of the National Center for Preventive Programs and Disease Control (Cenaprece) of the Ministry of Health, said that the said official Mexican standard for the detection, diagnosis, treatment, epidemiological surveillance of benign growth of the prostate and prostate cancer "represents a great success that involves new challenges, because it is essential that the authorities and health institutions take the necessary steps to create the conditions necessary for their implementation, Mexicans. "
In this context, he stressed the need to update the basic table and catalog of health sector inputs so that health facilities have all the treatment options established in NOM-048. the "Physician's Guide to Prostate Care" with health professionals across the country, for their knowledge and application to the benefit of patients.
The clinical practice guidelines of the National Center for Technological Excellence in Health (Cenetec), as well as the various health facilities, for its approval with NOM-048 should also be updated.
In turn, Dr. Samuel Rivera, Medical Oncologist and Past President of the Mexican Society of Oncology (SMeO), mentioned that given the challenges posed by the fragmentation of our health system, "This standard is an instrument that the mandatory compliance, will address the problem of prostate cancer in its entirety in health facilities, prevention and timely detection, its diagnostic care and even the treatment at advanced stages.
This standard becomes an important element, he said, because with the right treatment at the right time, it will be possible to realize that patients can fend for themselves and continue to be productive.
The oncologist acknowledged that at present more than 70% of men with prostate cancer are diagnosed at an advanced stage and that more than 90% will develop bone metastases, a complication that deteriorates the quality of life and in many cases it is a cause of death. (Cecilia Higuera Albarrán)
print
[ad_2]
Source link
